News We’re Watching: Two Join Illumina Board, FDA Plans Health Equity Meeting, Pre-Eclampsia Test Cleared
This week, Illumina’s board added two independent members; the VA and the FDA agreed to collaborate on supply chain issues; and Think Surgical, Thermo Fisher Scientific and Blue Earth all landed FDA clearances.
You may also be interested in...
News We’re Watching: Boston Sci Launches Embold, Lumox Bacterial Infection Test Cleared, Canada Bets On Isotopes
This week, Boston Scientific introduced its Embold line of embolization coils; the CEO of Precision Lens was killed in a plane crash; a test that can detect bacterial respiratory infections announced FDA clearance; and CDRH planned to get writing training for employees.
Francis deSouza resigned as CEO and chairman of Illumina just a few weeks after winning the support of shareholders. General counsel Charles Dadswell will take over as interim CEO.
Abbott is investing millions of dollars in its Diversity in Research Office to diversify clinical trials in the industry.